Insights into Crystallization of Neuronal Nicotinic α4β2 Receptor in Polarized Lipid Matrices
Obtaining high-resolution 3D structures of membrane proteins through X-ray crystallography remains a longstanding bottleneck in the field of structural biology. This challenge has led to the optimization of purification methods to acquire high-yielding, pure proteins suitable for crystallization. In this study, we performed crystallization screenings of purified human α4β2 nAChR using a polarized in meso method. After reconstituting the detergent-solubilized α4β2 nAChR into the LCP matrix, the samples were incubated in a polarized lipid matrix using the RMP@LMx device developed in our laboratory. The results showed that under these conditions, the α4β2-nAChR-LFC 16 complex gave a mobile fraction >0.8, suggesting that its diffusion in the polarized lipid matrix is favorable for crystal nucleation. Voltages above 70 mV restricted crystal formation due to sample dehydration. Furthermore, a lipid analysis using UPLC-ESI MS/MS revealed a profile necessary for preserving protein integrity and promoting diffusion across the LCP. We harvested a single crystal and subjected it to X-ray diffraction, resulting in reflections comparable to previous studies of the muscle-type nAChR from Torpedo californica. X-ray diffraction of a single crystal gave distinct low-resolution diffractions of protein nature. These findings lay the groundwork for further optimization of membrane protein crystallization in polarized in meso phases.
Authors
- Juan C. Villalobos‐Santos
- Orestes Quesada
- José A. Lasalde‐Dominicci (ORCID: https://orcid.org/0000-0002-1290-5830)
- Josué A. Rodríguez-Cordero (ORCID: https://orcid.org/0000-0002-9174-6769)
- Mallerie Carrasquillo-Rivera
Institutions
- University of Puerto Rico at Río Piedras (PR)
Publication Details
- Journal
- Crystals
- Published
- 2024-10-12
- DOI
- https://doi.org/10.3390/cryst14100889
- Citations
- 1
- Primary Topic
- Lipid Membrane Structure and Behavior
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- National Institutes of Health
- Argonne National Laboratory